Medicare Enrolled

Dr. George Yazigi, M.D.

Interventional Cardiology · Orlando, FL
2151 CONSULATE DR STE 17, Orlando, FL 32837
4076306630
Registered in NPPES since 2017
NPI: 1083155345 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yazigi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yazigi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yazigi

Dr. George Yazigi is an interventional cardiology specialist in Orlando, FL, with 9 years of NPI registration.

Between the years covered by Open Payments, Dr. Yazigi received a total of $16,262 from 28 pharmaceutical and/or device companies across 146 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yazigi is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years of NPI registration $16,262 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 158191 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$16,262
Total received (2020-2024)
Avg $3,252/year across 5 years
Top 33% in FL for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
146
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,349
2023
$1,961
2022
$10,109
2021
$660
2020
$184

Payments by company (2024)

Penumbra, Inc.
$2,280
Medtronic, Inc.
$329
ASAHI INTECC USA, INC.
$238
ABIOMED
$178
Edwards Lifesciences Corporation
$157
ShockWave Medical, Inc
$111
Inari Medical, Inc.
$28
CORDIS US CORP.
$26
Top 3 companies account for 85.0% of 2024 payments
All-time payments by company (2020-2024) ›
Penumbra, Inc.
$7,178
Abbott Laboratories
$3,048
Medtronic, Inc.
$884
Boston Scientific Corporation
$684
ShockWave Medical, Inc
$570
Bard Peripheral Vascular, Inc.
$539
E.R. Squibb & Sons, L.L.C.
$461
AstraZeneca Pharmaceuticals LP
$404
Edwards Lifesciences Corporation
$344
HeartFlow, Inc.
$256
CathWorks, Inc.
$252
ASAHI INTECC USA, INC.
$238
Astellas Pharma US Inc
$217
ABIOMED
$204
W. L. Gore & Associates, Inc.
$191
CORDIS US CORP.
$128
Amgen Inc.
$100
Teleflex LLC
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$89
Chiesi USA, Inc.
$72
Bayer Healthcare Pharmaceuticals Inc.
$61
Bayer HealthCare Pharmaceuticals Inc.
$58
PFIZER INC.
$52
CARDIVA MEDICAL, INC.
$45
Inari Medical, Inc.
$28
Kiniksa Pharmaceuticals, Ltd.
$26
BOSTON SCIENTIFIC CORPORATION
$25
SANOFI-AVENTIS U.S. LLC
$15
Top 3 companies account for 68.3% of all-time payments
Associated products mentioned in payments ›
Arcalyst · BRILINTA · CAMZYOS · CAPSUREFIX NOVUS MRI SURESCAN · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · CoreValve Evolut · DIAMONDBACK CORONARY · ELIQUIS · ENDURANT IIS · EXCLUDER Conformable AAA Endoprosthesis with Active Control · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRANGIO · FFRct · FLOWTRIEVER CATHETER · General - Therapies · Impella · Indigo System · JARDIANCE · KENGREAL · Kerendia · LEXISCAN · MANTA · MICRA · MYNX CONTROL · ONYX FRONTIER · PERIPHERAL VASCULAR · Repatha · S · SAPIEN 3 Ultra RESILIA · SELECTSECURE · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · WATCHMAN · WATCHMAN Access System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an interventional cardiology specialist in Orlando?
Compare interventional cardiologists in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse interventional cardiologists nearby

Geographic Context

Interventional cardiologists in nearby ZIP areas
28
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
CENTRAL FLORIDA BEHAVIORAL HOSPITAL
4.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yazigi is an interventional cardiology specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Yazigi receive payments from pharmaceutical companies?
Yes. Dr. Yazigi received a total of $16,262 from 28 companies across 146 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Yazigi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →